Science ❯ Biotechnology

Pharmaceuticals

Drug Development Vaccine Development Clinical Trials Clinical Research Drug Delivery Systems Drug Discovery Antibody Development Antibiotic Development Weight Loss Drugs Biosanitary Applications

Roche to Acquire PathAI for $750 Million Upfront Plus Up to $300 Million in Milestones

The companies expect to close in the second half of 2026 pending required approvals.

Regeneron and Telix Form 50/50 Partnership to Develop Targeted Radiopharmaceuticals

Mexico Clears Takeda’s Qdenga Dengue Vaccine for Private-Sector Sale

MIT Tests Biodegradable Pill That Signals When It’s Swallowed

Spanish-Led Spinal Cord Implant Project Seeks Investors to Advance Toward Human Trials

MoonLake Immunotherapeutics Investors Face Lead‑Plaintiff Deadline in Securities Fraud Suits

Janux Plunges on Mixed Phase 1 Prostate Cancer Data for JANX007

Polymer Lets Insulin Cross Skin in Animals, Matching Injections in Early Tests

Centessa Prices $250 Million ADS Offering at $21.50 as Shares Hit Record High

Sheffield's M102 Slows Motor Neurone Disease in Mice

Biovac Opens Cape Town Product Development Lab to Advance Africa’s Vaccine Capacity

Biogen Licenses Vanqua’s Preclinical C5aR1 Drug in Deal Worth Up to $1.06 Billion

Russia’s Flu Season Starts Slowly as Hospitalizations Tick Up

Santander Warns of 286% Surge in Weight-Loss Jab Scams Since January

AI-Guided Antibiotic Enterololin Targets Crohn’s-Linked Bacteria

CSL Secures VarmX Acquisition Option, Funding Phase 3 of Factor Xa Reversal Drug

Russia Says mRNA Cancer Vaccine Enteromix Is Ready After Preclinical Testing, Eyes Approval

Argentine Researchers Validate RAC1 Blockade to Protect the Liver in Fulminant Hepatitis

Engineered Antibody Transport Vehicle Boosts Alzheimer’s Antibody Delivery to Mouse Brain

FDA Flags Possible License Revocation for Sarepta’s Elevidys